Unbound MEDLINE

Intermediate vancomycin susceptibility in a community-associated MRSA clone. Emerging infectious diseases [Emerg Infect Dis] Journal article

 
TitleIntermediate vancomycin susceptibility in a community-associated MRSA clone.
Author(s)Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF 
InstitutionDivision of Infectious Diseases, University of California, San Francisco General Hospital, 94110, USA. christopher.graber@ucsf.edu
SourceEmerg Infect Dis 2007 Mar; 13(3):491-3.
AbstractWe describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.
Languageeng
Pub Type(s)Journal Article
PubMed ID17552110
  
Advertise on this site.